Abstract
Recent studies have highlighted a significant association between the severity of atherosclerosis and bone mineral density (BMD) among healthy subjects, although its connection to angiographically determined peripheral artery disease (PAD) has never been investigated. We evaluated the connection between the angiographic severity and site specificity of peripheral atherosclerosis and osteoporosis among patients with chronic lower limb ischemia. In our cross-sectional study we investigated 172 patients with PAD. The anatomic sites of the lesions were analyzed. The severity of atherosclerosis was diagnosed using the Bollinger angiographic score (BS). BMD was measured at the lumbar spine (l-BMD) and at femoral (f-BMD) and radial (r-BMD) sites by dual-energy X-ray absorptiometry. Dyslipidemia, the level of vitamin D3, and different bone turnover markers were also noted. Among PAD patients, regardless of the lesion site, we did not find any association between BMD and BS. Among patients with iliac disease, BS was associated with l-BMD (p = 0.038, r = −0.467) and with f-BMD (p = 0.002, r = −0.642). The level of r-BMD among patients with iliac disease was not associated with BS (p = 0.233, r = −0.306). We did not find any difference between the group of patients with and that without dyslipidemia and low or normal levels of vitamin D3. Our results show a connection between the severity of atherosclerosis and osteoporosis among patients with PAD, specific to the site of the lesion. The findings regarding dyslipidemia, bone markers, and site specificity support the hypothesis that reduced blood flow is the key factor responsible for the inverse association of BMD with atherosclerosis.
Similar content being viewed by others
References
Hyder JA, Allison MA, Criqui MH, Wright CM (2007) Association between systemic calcified atherosclerosis and bone density. Calcif Tissue Int 80:301–306
Mangiafico RA, Russo E, Riccobene S, Pennisi P, Mangiafico M, D’Amico F, Fiore CE (2006) Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab 24:125–131
von Muhlen D, Allison M, Jassal SK, Barrett-Connor E (2009) Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study. Osteoporos Int 20:2071–2078
von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278
Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B (1994) Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13:611–614
Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, Zhang Y, Kiel DP (2004) Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 34:557–561
Jensky NE, Hyder JA, Allison MA, Wong N, Aboyans V, Blumenthal RS, Schreiner P, Carr JJ, Wassel CL, Ix JH, Criqui MH (2011) The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis. J Bone Miner Res 26:2702–2709
Lupattelli G, Scarponi AM, Vaudo G, Siepi D, Roscini AR, Gemelli F, Pirro M, Latini RA, Sinzinger H, Marchesi S, Mannarino E (2004) Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism 53:744–748
Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49:211–217
Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680–687
Stojanovic OI, Lazovic M, Vuceljic M (2011) Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch Med Sci 7:179–188
Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158:1–235
Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A (2010) Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? Curr Vasc Pharmacol 8:720–730
Biver E, Chopin F, Coiffier G, Brentano TF, Bouvard B, Garnero P, Cortet B (2012) Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Joint Bone Spine 79:20–25
Chailurkit L, Kruavit A, Rajatanavin R, Ongphiphadhanakul B (2011) The relationship of fetuin-A and lactoferrin with bone mass in elderly women. Osteoporos Int 22:2159–2164
Mori K, Emoto M, Inaba M (2012) Fetuin-A and the cardiovascular system. Adv Clin Chem 56:175–195
Szeberin Z, Fehervari M, Krepuska M, Apor A, Rimely E, Sarkadi H, Szeplaki G, Prohaszka Z, Kalabay L, Acsady G (2011) Serum fetuin-A levels inversely correlate with the severity of arterial calcification in patients with chronic lower extremity atherosclerosis without renal disease. Int Angiol 30:474–475
Ford ML, Tomlinson LA, Smith ER, Rajkumar C, Holt SG (2010) Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant 25:1853–1858
Shioi A, Nishizawa Y (2009) Vascular calcification in chronic kidney disease: pathogenesis and clinical implications. J Ren Nutr 19:78–81
Fodor D, Bondor C, Albu A, Muntean L, Simon SP, Poanta L, Craciun A (2011) Relation between intima-media thickness and bone mineral density in postmenopausal women: a cross-sectional study. Sao Paulo Med J 129:139–145
Choi SH, An JH, Lim S, Koo BK, Park SE, Chang HJ, Choi SI, Park YJ, Park KS, Jang HC, Shin CS (2009) Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin Endocrinol (Oxf) 71:644–651
Beer S, Saely CH, Hoefle G, Rein P, Vonbank A, Breuss J, Gaensbacher B, Muendlein A, Drexel H (2010) Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men. Osteoporos Int 21:1695–1701
Bollinger A, Breddin K, Hess H, Heystraten FM, Kollath J, Konttila A, Pouliadis G, Marshall M, Mey T, Mietaschk A, Roth FJ, Schoop W (1981) Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 38:339–346
Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57
Holick MF (2000) Calcium and vitamin D. Diagnostics and therapeutics. Clin Lab Med 20:569–590
Maes C, Carmeliet G, Schipani E (2012) Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol 8:358–366
Hung SP, Ho JH, Shih YR, Lo T, Lee OK (2012) Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res 30:260–266
Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520–528
Persy V, D’Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15:405–416
Acknowledgments
We warmly thank Rachel Ewings and Daniel Loganathan for English correction, Renáta Dudás for data management, and Edit Máté for the BMD screening.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Fehérvári, M., Sarkadi, H., Krepuska, M. et al. Bone Mineral Density is Associated with Site-Specific Atherosclerosis in Patients with Severe Peripheral Artery Disease. Calcif Tissue Int 93, 55–61 (2013). https://doi.org/10.1007/s00223-013-9727-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-013-9727-5